Latest News
DexCom, Inc.
- DexCom, Inc. Estimates – SIX:DXCM.USD
- Dexcom G7 improves glucose outcomes in adults with Type 2 diabetes, study finds
- DexCom Inc. stock underperforms Wednesday when compared to competitors
- DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT Study
- Dexcom Study Redefines Diabetes Care for Non-Insulin Type 2 Patients
- Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin
- Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
- Dexcom Hit With New Lawsuits Over G7 Monitor Failures
- ShinyHunters new leak site lists O’Reilly and Dexcom breaches
- Dexcom reports on access, attitudes to diabetes technology
- Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care
- Why DexCom Could Be the Big Winner Out of Oura’s IPO
Headlines from the last 30 days, linking to the original publishers. See all market news →